REG - Plus500 Ltd - Directorate Change

Plus500Announcement

15/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230915:nRSO5251Ma&default-theme=true

RNS Number : 5251M  Plus500 Limited  15 September 2023

 

15 September 2023

 

Plus500 Ltd.

 

("Plus500", the "Company", or together with its subsidiaries, the "Group")

 

Directorate Change

 

Plus500, a global multi‐asset fintech group operating proprietary
technology‐based trading platforms, confirms that, having completed her
three-year term as an External Director under the provisions of Israel's
Companies Law, 5759-1999 ("Companies Law"), following her appointment to the
Board by shareholders at the Company's 2020 AGM held on 16 September 2020, Ms.
Anne Grim, our Senior Independent Non-Executive Director and External Director
is required to step down from the Board of Directors effective as of today.

The Company intends to convene an EGM later in 2023 for the reappointment of
Ms. Grim as an independent Non-Executive Director and External Director, in
accordance with the provisions of the Companies Law.

The Company also announces today, in accordance with Listing Rule 9.6.11(3),
that Prof. Varda Liberman, our Independent Non-Executive Director and Chair of
the Regulatory & Risk Committee, will replace Ms. Anne Grim as the Senior
Independent Director, with immediate effect.

 

For further details

Plus500 Ltd.
 Elad Even-Chen, Chief Financial Officer  +972 4 8189503

 Owen Jones, Head of Investor Relations   +44 (0) 7551 654208

                      ir@Plus500.com (mailto:ir@Plus500.com)

 Dentons Global Advisors

 James Melville-Ross                      +44 (0)20 7664 5095

 James Styles                             plus500@dentonsglobaladvisors.com (mailto:plus500@dentonsglobaladvisors.com)

 Leah Dudley

 

About Plus500

 

Plus500 is a global multi‐asset fintech group operating proprietary
technology‐based trading platforms. Plus500 offers customers a range of
trading products, including OTC ("Over‐the‐Counter" products, namely
Contracts for Difference (CFDs)), share dealing, as well as futures and
options on futures.

The Group retains operating licences and is regulated in the United Kingdom,
Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the
Seychelles, the United States, Estonia, Japan, the UAE and the Bahamas and
through its OTC product portfolio, offers more than 2,500 different underlying
global financial instruments, comprising equities, indices, commodities,
options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group
can trade its OTC products in more than 50 countries and in 30 languages.

Plus500's trading platforms are accessible from multiple operating systems
(Windows, iOS and Android) and web browsers. Customer care is and has always
been integral to Plus500, as such, OTC customers cannot be subject to negative
balances. A free demo account is available on an unlimited basis for OTC
trading platform users and sophisticated risk management tools are provided
free of charge to manage leveraged exposure and stop losses to help customers
protect profits, while limiting capital losses.

Plus500 shares have a premium listing on the Main Market of the London Stock
Exchange (symbol: PLUS) and are a constituent of the FTSE 250 index.
www.plus500.com (http://www.plus500.com) .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEANNLFSEDEFA